Searched for
SUM PHARMA
How Sensex, Nifty rallied 200% under PM Modi's record-breaking tenureIndian equity markets delivered strong long-term returns during Prime Minister Narendra Modi’s tenure, with the Sensex and Nifty gaining ar...- Sensex down over 10K points from Dec peak. Should MF investors buy the dip, hold positions, or wait on sidelines?The BSE Sensex has fallen over 10,000 points from its peak. Market experts suggest this presents a buying opportunity for long-term investo...
- What running a business in India actually looks like: Nightmare of CEOs these days is conversion of commercial disputes into criminal casesA corporate crisis manager describes how business disputes in India are increasingly being turned into criminal cases, exposing executives ...
- Market in consolidation phase, break above 24,600 crucial for trend shift: Gautam ShahIndian stock markets are seeing a shift. Leadership is narrowing, with energy, PSU, metals, real estate, and pharma sectors poised for grow...
- ETMarkets Smart Talk | Financials, industrials, healthcare top picks for FY27: Nimesh ChandanDespite geopolitical tensions and rising oil prices, Nimesh Chandan of Bajaj Finserv AMC believes India's structural economic story remains...
- ETMarkets Smart Talk| FY26 a year of consolidation, not breakdown; global stability key for revival in FY27: Somil MehtaIndian markets experienced consolidation in FY26 due to global headwinds, but underlying economic strength remains. FY27 revival hinges on ...
- FIIs sell Indian equities worth Rs 1.6 lakh cr since outbreak of Iran-US war. Where are they going and when will they come back?Foreign institutional investors sold Indian equities for 27 straight sessions, triggering steep market losses amid geopolitical tensions an...
- ETMarkets Smart Talk | FY26 a year of consolidation, not breakdown; global stability key for revival in FY27: Somil MehtaIndian markets experienced consolidation in FY26 due to global headwinds, but underlying economic strength remains. FY27 revival hinges on ...
- Mankind Pharma allocates Rs 40 crore to help COVID patients with oxygen cylinders,concentratorsThe last few months have been traumatic as the country is grappling with a deadly second wave of the pandemic and medical oxygen in India h...
- Stock pick of the week: Why Sun Pharma can be a good long-term betSun Pharma has clarified that the spike in its unsecured loans in 2017-18 was on account of a settlement it had reached with a thirdparty— ...
- Which are the Sharia-compliant mutual fund schemes in India?There are only three Sharia-compliant mutual fund schemes in India—Tata Ethical, Taurus Ethical and Reliance ETF Shariah BeES.
- SPARC gets I-T dept demand notice for Rs 27.30 croreThe company is contesting the demand and would file an appropriate appeal against this order within the stipulated period.
- Sun Pharma arm SPARC gets I-T demand notice for Rs 32.87 croreThe company is contesting the demand and will file an appropriate appeal against this under the applicable provisions of the Income Tax Act...
- Cipla arm to sell stake in Four M Propack to Shriji PolymersGoldencross Pharma Pvt Ltd has entered into a definitive agreement to sell its 100 per cent equity stake in Four M Propack Ltd, India to Sh...
- SPARC, Sun Pharma drop on USFDA revocation of approvalShares of SPARC closed 2.62 per cent lower at Rs 375.80 after hitting the day's low of Rs 368.50 on the exchange. Parent Sum Pharma ended 3...
- Torrent Pharma to acquire Zyg Pharma for an undisclosed sumThe acquisition will help the company strengthen its position in niche dermatological segment, especially in developed markets like the US ...
- Sun Pharma litigation to impact earnings, P/E multiples: AnalystsAccording to analysts at CLSA, the litigation settlement is higher than expectation. They expect 2.5 per cent earnings downgrade on cash ou...
- Lupin acquires majority stake in South African marketing coDrug firm Lupin today said it has acquired a majority stake in a South African marketing company for an undisclosed sum marking its entry i...
- Ajanta Pharma out-licences product technology to TaiwanAjanta Pharma Ltd will out-licence technology of its anti-scar product 'Vaniza' to Orient Europharma of Taiwan.
- Aurobindo arm acquires Dutch co PharmacinThis is Aurobindo's second acquisition in Europe after it took over UK's Milpharm early this year.
Load More
